Pharmaceutical

SciRhom secures $70m for autoimmune diseases treatments

SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.

Jul 10, 2024 - 04:00
SciRhom secures $70m for autoimmune diseases treatments
SciRhom has secured €63m ($70m) in a Series A funding round to develop iRhom2-targeting therapeutics for autoimmune diseases.
Read the original article

Tags:

Previous Article

Roche relaunches refillable wet AMD implant two years after recall

Next Article

Taiho exercises option for Arcus Biosciences’ quemliclustat in Asia

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for solid tumours

FDA approves Daiichi Sankyo-AstraZeneca’s Enhertu for s...

Apr 9, 2024

STAT+: Pharmalittle: State Medicaid programs seek discounts for Wegovy; congressional PBM bills work around the fringes

STAT+: Pharmalittle: State Medicaid programs seek disco...

Jul 26, 2023

Half of people worldwide at risk of developing mental health condition by age 75, per new study

Half of people worldwide at risk of developing mental h...

Aug 9, 2023